These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 34380865)

  • 1. The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis.
    Zhao HN; Jiang M; Sun MJ; Dai C
    Saudi J Gastroenterol; 2021; 27(4):191-200. PubMed ID: 34380865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids.
    Narula N; Marshall JK; Colombel JF; Leontiadis GI; Williams JG; Muqtadir Z; Reinisch W
    Am J Gastroenterol; 2016 Apr; 111(4):477-91. PubMed ID: 26856754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparable Long-Term Outcomes of Cyclosporine and Infliximab in Patients With Steroid-Refractory Acute Severe Ulcerative Colitis: A Meta-Analysis.
    Szemes K; Soós A; Hegyi P; Farkas N; Erős A; Erőss B; Mezősi E; Szakács Z; Márta K; Sarlós P
    Front Med (Lausanne); 2019; 6():338. PubMed ID: 32039218
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis.
    Jia X; Guo R; Hu Z; Liu J; Liu J; Li B; Yang Q; He J
    Medicine (Baltimore); 2020 Oct; 99(44):e22894. PubMed ID: 33126341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective Study.
    Nasuno M; Miyakawa M; Tanaka H; Motoya S
    Digestion; 2017; 95(1):67-71. PubMed ID: 28052276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pooled analysis of the comparative efficacy between tacrolimus and infliximab for ulcerative colitis.
    Liu YJ; Fan H; Zhen WW; Yu X; Chen JT; Wang CD
    Medicine (Baltimore); 2018 Aug; 97(32):e11440. PubMed ID: 30095612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab versus cyclosporine for severe ulcerative colitis refractory to steroids: A protocol for systematic review and meta-analysis.
    Wu D; Yang Z; Zhao C; Yao L
    Medicine (Baltimore); 2018 Oct; 97(41):e12657. PubMed ID: 30313056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Safety and Efficacy of Tacrolimus versus Infliximab for Active Ulcerative Colitis.
    Takeuchi K; Shimoyama T; Yamamoto T
    Dig Dis; 2018; 36(2):106-112. PubMed ID: 29050007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.
    Nelson R; Liao C; Fichera A; Rubin DT; Pekow J
    Inflamm Bowel Dis; 2014 Jan; 20(1):14-20. PubMed ID: 24297054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.
    Ordás I; Domènech E; Mañosa M; García-Sánchez V; Iglesias-Flores E; Peñalva M; Cañas-Ventura A; Merino O; Fernández-Bañares F; Gomollón F; Vera M; Gutiérrez A; Garcia-Planella E; Chaparro M; Aguas M; Gento E; Muñoz F; Aguirresarobe M; Muñoz C; Fernández L; Calvet X; Jiménez CE; Montoro MA; Mir A; De Castro ML; García-Sepulcre MF; Bermejo F; Panés J; Esteve M
    Am J Gastroenterol; 2017 Nov; 112(11):1709-1718. PubMed ID: 28675163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-Term and Long-Term Outcomes of Infliximab and Tacrolimus Treatment for Moderate to Severe Ulcerative Colitis: Retrospective Observational Study.
    Otsuka T; Ooi M; Tobimatsu K; Wakahara C; Watanabe D; Adachi S; Yasutomi E; Yamairi H; Ku Y; Yoshida M; Hoshi N; Kodama Y
    Kobe J Med Sci; 2018 Dec; 64(4):E140-E148. PubMed ID: 30728340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
    Fernández-Salazar L; Muñoz F; Barrio J; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; Fernández N; Sánchez-Ocaña R; Joao D; Santos F
    Scand J Gastroenterol; 2016; 51(2):186-95. PubMed ID: 26200929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of short-term therapeutic efficacy between infliximab and tacrolimus for moderate to severe ulcerative colitis.
    Yamagami H; Nishida Y; Nagami Y; Hosomi S; Yukawa T; Otani K; Tanaka F; Taira K; Kamata N; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y
    Rom J Intern Med; 2017 Sep; 55(3):151-157. PubMed ID: 28222041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic therapies for severe steroid refractory hospitalized ulcerative colitis: A network meta-analysis.
    Komaki Y; Komaki F; Micic D; Yamada A; Suzuki Y; Sakuraba A
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1143-1151. PubMed ID: 27957761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.
    Armuzzi A; Pugliese D; Danese S; Rizzo G; Felice C; Marzo M; Andrisani G; Fiorino G; Nardone OM; De Vitis I; Papa A; Rapaccini GL; Guidi L
    Inflamm Bowel Dis; 2014 Aug; 20(8):1368-74. PubMed ID: 24983979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review: Sequential Rescue Therapy in Severe Ulcerative Colitis: Do the Benefits Outweigh the Risks?
    Narula N; Fine M; Colombel JF; Marshall JK; Reinisch W
    Inflamm Bowel Dis; 2015 Jul; 21(7):1683-94. PubMed ID: 25839775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Short- and Long-Term Therapeutic Outcomes of Infliximab- versus Tacrolimus-Based Strategies for Steroid-Refractory Ulcerative Colitis.
    Endo K; Onodera M; Shiga H; Kuroha M; Kimura T; Hiramoto K; Kakuta Y; Kinouchi Y; Shimosegawa T
    Gastroenterol Res Pract; 2016; 2016():3162595. PubMed ID: 26904108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis.
    Song EM; Oh EH; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2463-2470. PubMed ID: 33783045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.
    Sjöberg M; Walch A; Meshkat M; Gustavsson A; Järnerot G; Vogelsang H; Hertervig E; Novacek G; Friis-Liby I; Blomquist L; Angelberger S; Karlen P; Grännö C; Vilien M; Ström M; Verbaan H; Hellström PM; Dejaco C; Magnuson A; Halfvarson J; Reinisch W; Tysk C
    Inflamm Bowel Dis; 2012 Feb; 18(2):212-8. PubMed ID: 21438096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effectiveness of Tacrolimus and Infliximab in Hospitalized Patients With Ulcerative Colitis.
    Takahashi T; Shiga H; Tarasawa K; Shimoyama Y; Naito T; Moroi R; Kuroha M; Kakuta Y; Fushimi K; Fujimori K; Kinouchi Y; Masamune A
    Clin Transl Gastroenterol; 2024 Jan; 15(1):e00642. PubMed ID: 37753937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.